Noninvasive optical imaging of firefly luciferase reporter gene expression in skeletal muscles of living mice

Molecular Therapy

Volumn 4, Issue 4, 2001, Pages 297-306

  Wu, Joseph C ^a   Sundaresan, Gobalakrishnan ^a   Iyer, Meera ^a   Gambhir, Sanjiv S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Adenovirus; CCD camera; Gene therapy; Luciferase; Reporter gene imaging; Skeletal muscle

Indexed keywords

LUCIFERASE; VIRUS PROTEIN;

ADENOVIRUS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; AUTOPSY; CAMERA; CONTROLLED STUDY; CORRELATION FUNCTION; CYTOMEGALOVIRUS; ENZYME ACTIVITY; ENZYME ASSAY; GENE ACTIVITY; GENE DELETION; GENE EXPRESSION; GENE LOCATION; GENE MAPPING; GENE THERAPY; GENETIC TRANSDUCTION; IMAGING SYSTEM; IMMUNOCOMPETENCE; IN VITRO STUDY; IN VIVO STUDY; MONITORING; MOUSE; MOUSE STRAIN; NON INVASIVE MEASUREMENT; NONHUMAN; NUDE MOUSE; PROMOTER REGION; REPORTER GENE; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION; SKELETAL MUSCLE; STAINING; TIME;

ADENOVIRIDAE; ANIMALIA; CUCUMBER MOSAIC VIRUS; CYTOMEGALOVIRUS; MUS MUSCULUS;

EID: 0034760638     PISSN: 15250016     EISSN: None     Source Type: Journal    
DOI: 10.1006/mthe.2001.0460     Document Type: Article

References (46)

1. Adenovirus-mediated utrophin gene transfer mitigates the dystrophic phenotype of mdx mouse muscles
2. Adenovirus-mediated dystrophin minigene transfer improves muscle strength in adult dystrophic (MDX) mice
3. Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by intramuscular injection of plasmid DNA
4. Erythropoietin secretion and physiological effect in mouse after intramuscular plasmid DNA electrotransfer
5. Immune response after adenoviral gene transfer in syngeneic heart transplants: Effects of anti-CD4 monoclonal antibody therapy
6. Quantitative determination of adenovirus-mediated gene delivery to rat cardiac myocytes in vitro and in vivo
7. A mutant herpes simplex virus type 1 thymidine kinase reporter gene shows improved sensitivity for imaging reporter gene expression with positron emission tomography
8. Imaging adenoviral-directed reporter gene expression in living animals with positron emission tomography
9. Imaging of adenoviral-directed herpes simplex virus type 1 thymidine kinase reporter gene expression in mice with radiolabeled ganciclovir
10. Noninvasive imaging of herpes virus thymidine kinase gene transfer and expression: A potential method for monitoring clinical gene therapy
11. Repetitive, non-invasive imaging of the dopamine D2 receptor as a reporter gene in living animals
12. PET: The merging of biology and imaging into molecular imaging
13. Chemistries and colors of bioluminescent reactions: A review
14. Kinetics of the firefly luciferase catalyzed reactions
15. Reporter gene technology: The future looks bright
16. Reporter gene expression for monitoring gene transfer
17. Novel features of drosophila period Transcription revealed by real-time luciferase reporting
18. Spatial imaging of luciferase gene expression in transgenic fish
19. Visualizing gene expression in living mammals using a bioluminescent reporter
20. Photonic detection of bacterial pathogens in living hosts
21. Real-time monitoring of Escherichia coli O157:H7 adherence to beef carcass surface tissues with a bioluminescent reporter
22. Validation of a noninvasive, real-time imaging technology using bioluminescent Escherichia coli in the neutropenic mouse thigh model of infection
23. Visualizing the kinetics of tumor-cell clearance in living animals
24. Imaging brain structure and function, infection and gene expression in the body using light
25. In utero delivery of adeno-associated viral vectors: Intraperitoneal gene transfer produces long-term expression
26. The route of administration is a major determinant of the transduction efficiency of rat tissues by adenoviral recombinants
27. Systemic delivery of recombinant proteins by genetically modified myoblasts
28. Systemic delivery of human growth hormone by injection of genetically engineered myoblasts
29. Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy
30. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration
31. Cellular and humoral immune responses to viral antigens create barriers to lung-directed gene therapy with recombinant adenoviruses
32. Similarity of strain- and route-dependent murine responses to an adenovirus vector using the homologous thrombopoietin cDNA as the reporter genes
33. Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: Tolerization of factor IX and vector antigens allows for long-term expression
34. A differential efficiency of adenovirus-mediated in vivo gene transfer into skeletal muscle cells of different maturity
35. Interactions between the immune system and gene therapy vectors: Bidirectional regulation of response and expression
36. In vivo muscle gene transfer of full-length dystrophin with an adenoviral vector that lacks all viral genes
37. "Sero-switch" adenovirus-mediated in vivo gene transfer: Circumvention of anti-adenovirus humoral immune defenses against repeat adenovirus vector administration by changing the adenovirus serotype
38. Cyclophosphamide diminishes inflammation and prolongs transgene expression following delivery of adenoviral vectors to mouse liver and lung
39. Optical investigations of physiology: A study of intrinsic and extrinsic biomedical contrast
40. Direct correlation between positron emission tomographic images of two reporter genes delivered by two distinct adenoviral vectors
41. Quantification of target gene expression by imaging reporter gene expression in living animals
42. A simple technique for the rescue of early region I mutations into infectious human adenovirus type 5
43. Methods for construction of adenovirus vectors
44. Adenovirus-mediated transfer of a recombinant α 1-antitrypsin gene to the lung epithelium in vivo
45. Expression of unselected adenovirus genes in human cells co-transformed with the HSV-1 tk gene and adenovirus 2 DNA
46. Prolonged and effective blockade of tumor necrosis factor activity through adenovirus-mediated gene transfer